Editorial: Trajectory of soluble programmed cell death protein‐1 and ligand‐1 in HBV‐infected individuals treated with pegylated interferon—implications for stopping rules and the HBV cure programme

LINKED CONTENT This article is linked to Chen et al papers. To view these articles, visit https://doi.org/10.1111/apt.18131 and https://doi.org/10.1111/apt.18174

Saved in:

Bibliographic Details
Published in:	Alimentary pharmacology & therapeutics 2024-09, Vol.60 (5), p.650-651
Main Author:	Lok, James
Format:	Article
Language:	English
Subjects:	Antiviral Agents - therapeutic use Apoptosis B7-H1 Antigen - antagonists & inhibitors Cell death Hepatitis B - drug therapy Hepatitis B virus - drug effects Hepatitis B, Chronic - drug therapy Humans Interferon-alpha - therapeutic use Polyethylene Glycols - therapeutic use Programmed Cell Death 1 Receptor - antagonists & inhibitors
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!